Correlation Between Lixte Biotechnology and Biotricity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lixte Biotechnology and Biotricity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lixte Biotechnology and Biotricity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lixte Biotechnology Holdings and Biotricity, you can compare the effects of market volatilities on Lixte Biotechnology and Biotricity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lixte Biotechnology with a short position of Biotricity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lixte Biotechnology and Biotricity.

Diversification Opportunities for Lixte Biotechnology and Biotricity

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lixte and Biotricity is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and Biotricity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotricity and Lixte Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lixte Biotechnology Holdings are associated (or correlated) with Biotricity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotricity has no effect on the direction of Lixte Biotechnology i.e., Lixte Biotechnology and Biotricity go up and down completely randomly.

Pair Corralation between Lixte Biotechnology and Biotricity

Assuming the 90 days horizon Lixte Biotechnology Holdings is expected to generate 2.64 times more return on investment than Biotricity. However, Lixte Biotechnology is 2.64 times more volatile than Biotricity. It trades about 0.12 of its potential returns per unit of risk. Biotricity is currently generating about -0.05 per unit of risk. If you would invest  4.20  in Lixte Biotechnology Holdings on March 15, 2024 and sell it today you would earn a total of  2.70  from holding Lixte Biotechnology Holdings or generate 64.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Lixte Biotechnology Holdings  vs.  Biotricity

 Performance 
       Timeline  
Lixte Biotechnology 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lixte Biotechnology Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Lixte Biotechnology showed solid returns over the last few months and may actually be approaching a breakup point.
Biotricity 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotricity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in July 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Lixte Biotechnology and Biotricity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lixte Biotechnology and Biotricity

The main advantage of trading using opposite Lixte Biotechnology and Biotricity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lixte Biotechnology position performs unexpectedly, Biotricity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotricity will offset losses from the drop in Biotricity's long position.
The idea behind Lixte Biotechnology Holdings and Biotricity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.